ALN-TTR01

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameALN-TTR01
Drug Alias NameALN-TTR01
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsTransthyretin
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenPortugalUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlnylam Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A